A few weeks ago I wrote that Nvax just needs a catalyst.
The earnings have exceeded expectations spectacularly, 139 million in revenue vs 78 mil expected.
As it stands now, the stats are almost all where we want them:
Short interest at 33%
Days to cover at 17 days
Off-exchange short interest at staggering 63%
Shares available to borrow: 150 000. This is the lowest I've seen in a long time, usually its in the 500 000 range
Cost to borrow is the red flag for the squeeze at less than a percent.
Earnings are forcing the volume to go up too (the most important metric for a short squeeze). We are seeing 3 times the usual volume today.
Position: 1k shares at 9.5 average. I am a bagholder so keep that in mind when investing.